CHEBI:4887 - ethosuximide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name ethosuximide
ChEBI ID CHEBI:4887
Definition A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:131811
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C7H11NO2
Net Charge 0
Average Mass 141.16770
Monoisotopic Mass 141.07898
InChI InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)
InChIKey HAPOVYFOVVWLRS-UHFFFAOYSA-N
SMILES CCC1(C)CC(=O)NC1=O
Roles Classification
Biological Role(s): T-type calcium channel blocker
Any agent that interferes with the activity of T-type calcium channels.
Application(s): geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
anticonvulsant
A drug used to prevent seizures or reduce their severity.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing ethosuximide (CHEBI:4887) has role anticonvulsant (CHEBI:35623)
ethosuximide (CHEBI:4887) has role geroprotector (CHEBI:176497)
ethosuximide (CHEBI:4887) has role T-type calcium channel blocker (CHEBI:194338)
ethosuximide (CHEBI:4887) is a dicarboximide (CHEBI:35356)
ethosuximide (CHEBI:4887) is a pyrrolidinone (CHEBI:38275)
Incoming (R)-ethosuximide (CHEBI:60354) is a ethosuximide (CHEBI:4887)
(S)-ethosuximide (CHEBI:60355) is a ethosuximide (CHEBI:4887)
IUPAC Name
3-ethyl-3-methylpyrrolidine-2,5-dione
INNs Sources
éthosuximide WHO MedNet
ethosuximide ChemIDplus
ethosuximidum ChemIDplus
etosuximida ChemIDplus
Synonyms Sources
(±)-2-ethyl-2-methylsuccinimide ChemIDplus
2-ethyl-2-methylsuccinimide ChemIDplus
2-methyl-2-ethylsuccinimide ChemIDplus
3-ethyl-3-methyl-2,5-pyrrolidinedione ChEBI
3-ethyl-3-methylsuccinimide ChemIDplus
3-methyl-3-ethylpyrrolidine-2,5-dione ChemIDplus
3-methyl-3-ethylsuccinimide ChemIDplus
Aethosuximide ChemIDplus
α-ethyl-α-methylsuccinimide ChemIDplus
α-methyl-α-ethylsuccinimide ChemIDplus
Ethosuximide KEGG COMPOUND
γ-ethyl-γ-methyl-succinimide ChEBI
γ-methyl-γ-ethyl-succinimide ChemIDplus
Manual Xrefs Databases
1087 DrugCentral
3175 ChemSpider
C07505 KEGG COMPOUND
D00539 KEGG DRUG
DB00593 DrugBank
Ethosuximide Wikipedia
HMDB0014731 HMDB
LSM-5195 LINCS
View more database links
Registry Numbers Types Sources
117054 Reaxys Registry Number Reaxys
77-67-8 CAS Registry Number KEGG COMPOUND
77-67-8 CAS Registry Number ChemIDplus
77-67-8 CAS Registry Number NIST Chemistry WebBook
Citations Waiting for Citations Types Sources
12873507 PubMed citation ChEMBL
16606760 PubMed citation Europe PMC
1681105 PubMed citation ChEMBL
17011080 PubMed citation ChEMBL
17046248 PubMed citation ChEMBL
17451232 PubMed citation ChEMBL
17481896 PubMed citation ChEMBL
1847429 PubMed citation ChEMBL
18949032 PubMed citation Europe PMC
19005061 PubMed citation Europe PMC
1992141 PubMed citation ChEMBL
2061925 PubMed citation ChEMBL
21332949 PubMed citation Europe PMC
21945797 PubMed citation Europe PMC
2296016 PubMed citation ChEMBL
2308142 PubMed citation ChEMBL
3336019 PubMed citation ChEMBL
3820228 PubMed citation ChEMBL
8246220 PubMed citation ChEMBL
8627613 PubMed citation ChEMBL
8691481 PubMed citation ChEMBL
9016327 PubMed citation ChEMBL
Last Modified
07 February 2023